DIA
Drug Information Association Logo

Advanced Search

MM-DD-YYYY

Browse Articles

Search Articles 

Publication Title Author Date Volume Abstract
DIAJ Benefit/Risk Estimates in Clinical Trials Adil E. Shamoo 2011 45(05) View Abstract
DIAJ Japanese Guideline on Global Clinical Trials: Statistical Implications and Alternative Criteria for Assessing Consistency Florence Le Maulf,Kevin J. Carroll 2011 45(05) View Abstract
DIAJ Decision Making for a Companion Diagnostic in an Oncology Clinical Development Program Bernard Fine,Lee Kaiser 2011 45(05) View Abstract
DIAJ Establishing a Complete Drug Information Triad: Academic, Industry, and Hospital Training Elizabeth S Miller,Katie J. Suda,Anne M. Hurley,Mina Tadrous,Daniel Gharbawy 2011 45(05) View Abstract
DIAJ Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in Quebec Benoit Rouleau 2011 45(05) View Abstract
DIAJ Technical Requirements for Biopharmaceutics Classification System–based Biowaiver in China Ning Zhang 2011 45(05) View Abstract
DIAJ Results of a Survey of PhRMA Member Companies on Practices Associated With Multiregional Clinical Trials Nick R Scott,Tonya L Houck,Yoko Tanaka,Bruce Binkowitz,Belinda Field,Ekopimo O. Ibia,Andy Lee,Steven Talerico 2011 45(05) View Abstract
DIAJ Consistency of Treatment Effect Across Regions in Multiregional Clinical Trials, Part 2: Monitoring, Reporting, and Interpretation Soo Ouyang,Paul P. Gallo,Shailendra S. Menjoge,Yoko Tanaka,Bruce Binkowitz,Ekopimo O. Ibia,Gang Li,Hui Quan,Xiaolong Luo,Joshua Chen,Steven Talerico,Kimitoshi Ikeda 2011 45(05) View Abstract
DIAJ Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies Zheng Su 2011 45(06) View Abstract
DIAJ Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies 2011 45(06) View Abstract
DIAJ Review of: Fundamentals of US Regulatory Affairs, 7th ed. Edward Tabor 2011 45(06) View Abstract
DIAJ Certification for the Medical Science Liaison: An Idea Whose Time Has come---or Not Kenneth L Massey,Jane Chin,Jimmy Thomas Black 2011 45(06) View Abstract
DIAJ Medical Information Services in the Age of Social Media and New Customer Channels Lesley S. Fierro,Poonam A. Bordoloi,Michelle Clausen,Krupa Paranjpe,Andrew Gazo 2011 45(06) View Abstract
DIAJ Clinically Important Effects in New Drug Development Satoshi Hashigaki,Kanae Togo,Takashi Moriya,Keiji Imai 2011 45(06) View Abstract
DIAJ Consistency of Treatment Effect Across Regions in Multiregional Clinical Trials, Part 1: Design Considerations Soo Ouyang,Paul P. Gallo,Shailendra S. Menjoge,Yoko Tanaka,Bruce Binkowitz,Ekopimo O. Ibia,Gang Li,Hui Quan,Xiaolong Luo,Joshua Chen,Steven Talerico,Kimitoshi Ikeda 2011 45(05) View Abstract
DIAJ Assessment of Electronic Drug Information Research Availability in Alabama Pharmacies Michael G Kendrach,Bob Schrimsher,Maisha Kelly Freeman 2011 45(06) View Abstract
DIAJ Content Analysis of Off-label Drug Use: Reporting Print Media Coverage David A. Holdford,Avani D Joshi 2011 45(06) View Abstract
DIAJ Failure to Communicate: Medication Guide or Memory ? Louis A Morris,Morris S Whitcup 2011 45(06) View Abstract
DIAJ Evaluation of Drug Adverse Event Intake and Reporting in a Medical Information Service Robert Fuentes,Michael Hoopes,Gregory M Susla,Pamela D Allen 2011 45(06) View Abstract
DIAJ Impact of Different Regulatory Requirements for Trial Endpoints in Multiregional Clinical Trials Cynthia J. Girman,Shailendra S. Menjoge,Bruce Binkowitz,Carmen Mak,Anupam Agarwal,Ekopimo O. Ibia,Joshua Chen 2011 45(05) View Abstract
DIAJ Validation of Decision-enabling Tools: Showing That the Model Is Useful Stig J Wiklund 2011 45(06) View Abstract
DIAJ Points to Consider in Defining Region for a Multiregional Clinical Trial: Defining Region Work Stream in PhRMA MRCT Key Issue Team Michael A Rabbia,Yoko Tanaka,Bruce Binkowitz,Carmen Mak,Ekopimo O. Ibia,Brent Burger,Joshua Chen,Alex Zolotovitski 2011 45(05) View Abstract
DIAJ A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making Andreas I. Sashegyi 2011 45(06) View Abstract
DIAJ Letter to the Editor: Selection of the Time Points for a Thorough QTc Study Norman Stockbridge,Joanne Zhang 2011 45(06) View Abstract
DIAJ Multiregional Clinical Trials: An Introduction From an Industry Perspective Bruce Binkowitz,Ekopimo O. Ibia 2011 45(05) View Abstract
DIAJ A Longitudinal Model and Graphic for Benefit-risk Analysis, With Case Study Jonathan D. Norton 2011 45(06) View Abstract
DIAJ Letters to the Editor Norman Stockbridge,Lawrence Z Satin,Eoin O'Brien 2011 45(05) View Abstract
DIAJ Platelet Aggregation Quality Control in a Multicenter Phase 2 Clinical Trial James McRedmond 2011 45(06) View Abstract
DIAJ Program Chair Reflects Upon DIA 2011 Kenneth A. Getz 2011 45(05) View Abstract
DIAJ Ten-year Experience of the Evaluation of Ethnic Sensitivity Data Chia-Ling Hsiao 2011 45(06) View Abstract
DIAJ Editor's Commentary: Letters to the Editor, a New Publishing Partner, and Benefit-risk Estimation Rick Turner 2011 45(05) View Abstract
DIAJ Letter to the Editor 2011 45(06) View Abstract
DIAJ Fewer Drugs, Shorter Lives, Less Prosperity: The Impact of Comparative Effectiveness Research on Health and Wealth Peter J. Pitts 2011 45(06) View Abstract
DIAJ Preparing for a Safety Inspection Steve Jolley 2011 45(06) View Abstract
DIAJ Associate Editor's Commentary: The Danger of Shorting Drug Shortages Peter J. Pitts 2011 45(06) View Abstract
DIAJ Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk- Benefit Assessment John Doyle 2011 45(06) View Abstract
DIAJ Editor's Commentary: A Time for Reflection and Anticipation Rick Turner 2011 45(06) View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) Nov 01, 2012 Issue 9 View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) Aug 01, 2012 Issue 8 View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) May 01, 2012 Issue 7 View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) Feb 01, 2012 Issue 6 View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) Nov 01, 2011 Issue 5 View Abstract
GF Global Forum Aug 01, 2013 13(04) View Abstract
GF Global Forum Jun 01, 2013 13(03) View Abstract
GF Global Forum Apr 01, 2013 13(02) View Abstract
GF Global Forum Feb 01, 2013 13(01) View Abstract
GF Global Forum Dec 01, 2012 12(06) View Abstract
GF Global Forum Oct 01, 2012 12(05) View Abstract
GF Global Forum Aug 01, 2012 12(04) View Abstract
GF Global Forum Jun 01, 2012 12(03) View Abstract
GF Global Forum Apr 01, 2012 12(02) View Abstract
GF Global Forum Feb 01, 2012 12(01) View Abstract
GF Global Forum Dec 01, 2011 11(06) View Abstract
GF Global Forum Oct 01, 2011 11(05) View Abstract